Analysts predict that Itron, Inc. (NASDAQ:ITRI) will report sales of $606.08 million for the current quarter, according to Zacks. Six analysts have made estimates for Itron’s earnings, with the highest sales estimate coming in at $615.30 million and the lowest estimate coming in at $586.00 million. Itron reported sales of $486.75 million in the same quarter last year, which indicates a positive year-over-year growth rate of 24.5%. The company is scheduled to issue its next earnings report on Wednesday, November 7th.

On average, analysts expect that Itron will report full year sales of $2.45 billion for the current fiscal year, with estimates ranging from $2.44 billion to $2.45 billion. For the next financial year, analysts anticipate that the company will post sales of $2.53 billion per share, with estimates ranging from $2.47 billion to $2.58 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that cover Itron.

Itron (NASDAQ:ITRI) last posted its quarterly earnings results on Monday, August 6th. The scientific and technical instruments company reported $0.51 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.49 by $0.02. Itron had a negative net margin of 5.18% and a positive return on equity of 12.86%. The business had revenue of $585.89 million during the quarter, compared to analyst estimates of $592.12 million. During the same period in the previous year, the business posted $0.71 EPS. The company’s quarterly revenue was up 16.5% on a year-over-year basis.

ITRI has been the subject of several research reports. Guggenheim set a $73.00 price target on shares of Itron and gave the company a “buy” rating in a report on Monday, August 6th. Cowen set a $80.00 price target on shares of Itron and gave the company a “buy” rating in a report on Monday, August 6th. Canaccord Genuity set a $84.00 price target on shares of Itron and gave the company a “buy” rating in a report on Wednesday, June 6th. Argus raised shares of Itron from a “hold” rating to a “buy” rating and set a $72.00 price target for the company in a report on Wednesday, August 22nd. Finally, Zacks Investment Research raised shares of Itron from a “sell” rating to a “hold” rating in a report on Tuesday, June 5th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $80.18.

In other Itron news, insider Philip Mezey sold 16,694 shares of the business’s stock in a transaction dated Wednesday, August 22nd. The shares were sold at an average price of $65.04, for a total transaction of $1,085,777.76. Following the completion of the transaction, the insider now directly owns 93,341 shares of the company’s stock, valued at approximately $6,070,898.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Lynda L. Ziegler sold 978 shares of the business’s stock in a transaction dated Monday, July 2nd. The shares were sold at an average price of $59.30, for a total transaction of $57,995.40. Following the transaction, the insider now directly owns 13,894 shares of the company’s stock, valued at $823,914.20. The disclosure for this sale can be found here. Insiders own 2.32% of the company’s stock.

A number of institutional investors have recently bought and sold shares of ITRI. Municipal Employees Retirement System of Michigan raised its position in shares of Itron by 5.7% during the 1st quarter. Municipal Employees Retirement System of Michigan now owns 13,630 shares of the scientific and technical instruments company’s stock worth $975,000 after buying an additional 740 shares in the last quarter. US Bancorp DE raised its position in shares of Itron by 12.7% during the 2nd quarter. US Bancorp DE now owns 8,010 shares of the scientific and technical instruments company’s stock worth $481,000 after buying an additional 904 shares in the last quarter. Cubist Systematic Strategies LLC raised its position in shares of Itron by 21.6% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 5,125 shares of the scientific and technical instruments company’s stock worth $308,000 after buying an additional 909 shares in the last quarter. Wells Fargo & Company MN raised its position in shares of Itron by 1.4% during the 1st quarter. Wells Fargo & Company MN now owns 65,367 shares of the scientific and technical instruments company’s stock worth $4,676,000 after buying an additional 933 shares in the last quarter. Finally, Pinebridge Investments L.P. raised its position in shares of Itron by 3.0% during the 2nd quarter. Pinebridge Investments L.P. now owns 33,774 shares of the scientific and technical instruments company’s stock worth $2,028,000 after buying an additional 983 shares in the last quarter. 94.03% of the stock is owned by hedge funds and other institutional investors.

Shares of NASDAQ ITRI traded down $0.05 during midday trading on Thursday, hitting $65.90. The company’s stock had a trading volume of 167,933 shares, compared to its average volume of 272,077. Itron has a 1-year low of $55.26 and a 1-year high of $79.95. The company has a debt-to-equity ratio of 1.61, a quick ratio of 1.18 and a current ratio of 1.51. The firm has a market capitalization of $2.62 billion, a PE ratio of 21.68, a price-to-earnings-growth ratio of 1.14 and a beta of 0.91.

Itron Company Profile

Itron, Inc, a technology company, provides end-to-end solutions that measures, manages, and analyzes energy and water use worldwide. The company operates through three segments: Electricity, Gas, and Water. It offers standard electromechanical and electronic, gas, and water and heat meters; and smart electricity, gas, and water meters and communication modules.

Featured Article: How to Invest in an Index Fund

Get a free copy of the Zacks research report on Itron (ITRI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.